0001437749-23-004868.txt : 20230228 0001437749-23-004868.hdr.sgml : 20230228 20230228122321 ACCESSION NUMBER: 0001437749-23-004868 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221021 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nussbaum Ran CENTRAL INDEX KEY: 0001609805 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 23681764 MAIL ADDRESS: STREET 1: C/O KITE PHARMA, INC. STREET 2: 2225 COLORADO AVENUE CITY: SANTA MONICA STATE: CA ZIP: 90404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2022-10-21 2022-10-25 0001668243 UroGen Pharma Ltd. URGN 0001609805 Nussbaum Ran 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Ordinary Shares 2022-10-21 4 M 0 47999 5.94 A 1485168 I Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd Stock Option (right to buy) 5.94 2022-10-21 4 M 0 32723 0 D 2018-12-27 2022-12-27 Ordinary Shares 32723 0 I By Pontifax (Israel) III Limited Partnership Stock Option (right to buy) 5.94 2022-10-21 4 M 0 15276 0 D 2018-12-27 2022-12-27 Ordinary Shares 15276 0 I By Pontifax Cayman III Limited Partnership On October 25, 2022, the reporting person filed a Form 4 that inadvertently reported 1,481,927 shares of securities beneficially owned following reported transaction instead of 1,485,168 shares. /s/ Jason D. Smith, Attorney-in-Fact 2023-02-28